BriaCell Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2021 Biotech Investing
DEADLINE ALERT for PLUG, NEPT, BLU, RIDE: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders Biotech Investing
European Medicines Agency Validates Bristol Myers Squibb's Application for Opdivo as Adjuvant Treatment for Patients with Muscle-Invasive Urothelial Carcinoma Biotech Investing
U.S. Food and Drug Administration Approves Bristol Myers Squibb's and bluebird bio's Abecma , the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma Biotech Investing
BLU INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages BELLUS Health Inc. Investors with Large Losses to Secure Counsel Before Important Deadline in Securities Class Action - BLU Biotech Investing
DEADLINE ALERT for NEPT, BLU, RIDE, and CYDY: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Biotech Investing
Solarvest Bioenergy Inc. Announces Increase in Offering Size of Non-Brokered Private Placement to Existing Shareholders and Other Investors Biotech Investing
European Medicines Agency Validates Marketing Authorization Application for Sacituzumab Govitecan-Hziy for the Treatment of Metastatic Triple-Negative Breast Cancer Biotech Investing
INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
